Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
TATE & LYLE PLC	TATE	London S.E. +5 Other	1,072,249	674.5 GBX	Stock
TATE & LYLE PLC	TLYB	Deutsche Boerse AG	-	7.875 EUR
TATE & LYLE PLC	TLYB	Börse Stuttgart	-	7.855 EUR
TATE & LYLE PLC	TLYB	BOERSE MUENCHEN	-	8.005 EUR
TATE & LYLE PLC	TATYF	OTC Markets	2,904	8.625 USD
TATE & LYLE PLC	TATE	Berne S.E.	-	- CHF
TATE & LYLE PLC	TATYY	OTC Markets	1,067	34.21 USD	Stock

News (149)

Cyclo Therapeutics : Corporate Presentation	04-18	PU
Cyclo Therapeutics : Corporate Presentation	03-18	PU
Tate & Lyle : Board changes - March 2024	03-07	PU
Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024	03-07	CI
Dow Inc. Announces Chief Financial Officer Changes	23-10-24	CI
Cyclo Therapeutics : Corporate Presentation	23-10-04	PU
Cyclo Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K	23-07-31	PU
HealthStream : 2022 Shareholder Letter	23-07-10	PU
LEGGETT & PLATT INC : Change in Directors or Principal Officers, Regulation FD Disclosure (form 8-K)	23-06-22	AQ
Leggett & Platt Announces Executive Changes	23-06-22	CI
Leggett & Platt Announces Chief Financial Officer Changes	23-06-22	CI
Transcript : HealthStream, Inc. - Shareholder/Analyst Call	23-05-25
HUNTINGTON BANCSHARES INC /MD/ : Submission of Matters to a Vote of Security Holders (form 8-K)	23-04-24	AQ
Transcript : Huntington Bancshares Incorporated - Shareholder/Analyst Call	23-04-19
Cyclo Therapeutics : Factsheet	23-04-06	PU
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)	23-03-10	AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	23-02-23	AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)	22-11-21	AQ
Transcript : Leggett & Platt, Incorporated, Q3 2022 Earnings Call, Nov 01, 2022	22-11-01
Cyclo Therapeutics : Factsheet	22-08-17	PU
© 2022 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P0361 July 5, 2022 (Doc 1052) - Form 8-K	22-07-05	PU
Cyclo Therapeutics : Corporate Presentation	22-07-05	PU
CYCLO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-06-24	AQ
Prime Focus World N.V. cancelled the acquisition of Sports Ventures Acquisition Corp. from AKICV LLC, Empyrean Capital Overseas Master Fund, Ltd. managed by Empyrean Capital Partners, LP, Glazer Capital, LLC, HGC Investment Management Inc., Citadel Advisors LLC and others in a reverse merger transaction.	22-06-14	CI
Cyclo Therapeutics : Factsheet	22-06-03	PU
Cyclo Therapeutics : Factsheet	22-05-27	PU
Huntington Bancshares Incorporated : Submission of Matters to a Vote of Security Holders - Form 8-K	22-04-25	PU
HUNTINGTON BANCSHARES INC /MD/ : Submission of Matters to a Vote of Security Holders (form 8-K)	22-04-25	AQ
AAON : Annual Report (Form ARS)	22-03-31	PU
Transcript : Kontrol Technologies Corp., Q4 2021 Earnings Call, Mar 31, 2022	22-03-31
CYCLO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-03-02	AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)	22-02-24	AQ
Cyclo Therapeutics : CYTH Investor Presentation February 2022.pdf	22-02-23	PU
Artnet : After ‘Rigorous’ Review, Tate Has Concluded It Will Keep a Racist Mural on View, But Add a New Interpretation by a Contemporary Artist	22-02-16	PU
Prime Focus World N.V. entered into a entered into a letter of intent to acquire Sports Ventures Acquisition Corp. from AKICV LLC, Empyrean Capital Overseas Master Fund, Ltd. managed by Empyrean Capital Partners, LP, Glazer Capital, LLC, HGC Investment Management Inc., Citadel Advisors LLC and others for $1.3 billion in a reverse merger transaction.	22-01-24	CI
Cyclo Therapeutics : CYTH Investor Presentation January 22.pdf	22-01-05	PU
HealthStream : 2020 Annual Report	21-12-21	PU
HealthStream : 2019 Annual Report	21-12-21	PU
HealthStream : 2018 Annual Report	21-12-21	PU
HealthStream : 2017 Annual Report	21-12-21	PU
FREYR Signs Global SME Climate Commitment	21-11-10	PU
CYTH Investor Presentation November 2021[2].pdf	21-11-08	PU
CYTH Investor Presentation November 2021.pdf	21-11-08	PU
FREYR Battery : Further Strengthens Its Sustainability Team	21-10-11	PU
Transcript : DERMAdoctor, LLC., NovaBay Pharmaceuticals, Inc. - M&A Call	21-09-29

1234NextSee all

Companies (8)

MONDELEZ INTERNATIONAL, INC. 95 505 M $

Mondelez International, Inc. is one of the world's leading food processing groups. Net sales break down by family of products as follows: - cookies and snacks (48.9%): Barni, belVita, Chips Ahoy, Club Social, Enjoy Life Foods, Honey Maid, Kinh Do, LU, Or ...

AURIC MINING LIMITED 18 M $

Auric Mining Limited is an Australia-based gold exploration and development company. The Company has four projects in the Widgiemooltha area of Western Australia, the Widgiemooltha Gold project, including the Companyâs flagship Munda gold deposit, the J ...

IN THE F CO.,LTD. 37 M $

In the F CO.,LTD. is a Korea-based company engaged in the manufacture of apparels. The Company provides casual clothing, suits, sportswear, coats, blouses, jackets and other various fashion products under the brand names of JOINUS,YETTS, MAYPOLE, TRUGEN, ...

ULTIMA UNITED 4 M $

Ultima United Limited is an Australia-based property development company. The Company's rental properties segment includes rental income on rental properties at 3 Oak Street, Cannington, Western Australia (WA). The Company's properties include the Canning ...

GTI ENERGY LIMITED 7 M $

GTI Energy Limited is an Australia-based Company, which is engaged in exploring mineral tenements in the United States of America including Utah, Colorado and Wyoming. The Company's projects include Wyoming in situ recovery (ISR) and Henry Mountains. The ...

TATE & LYLE PLC 3 357 M $

Tate & Lyle PLC is engaged in providing ingredients and solutions to the food, beverage, and other industries. The Company operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The Food & Beverage Solutions segment o ...

TATE & LYLE PLC 3 357 M $

GTI RESOURCES LIMITED 7 M $

Insiders

Jeffrey W. Tate

Jeffrey Norman Tate

Jeffrey Tate

Jeffrey L.
Tate's current jobs include being the President & Chief Executive Officer at Nanosonic Products, Inc., the President, CEO, Secretary & Treasurer at Ferrazo Environmental Technologies, Inc., the President, CEO, Secretary & Treasurer at Sphingo Biotech, Inc., and the Director, Chief Operating & Quality Officer at Cyclo Therapeutics, Inc. Dr. Tate's former jobs include being the Vice President-Scientific & Regulatory Affairs at Natural Biologics LLC., the President at J Jireh Products, Inc., and the Principal at J.
Benson Tate Consultants LLC.
Dr. Tate obtained his undergraduate, graduate, and doctorate degrees from the University of Minnesota.

Jeffrey Tate

Presently, Jeffrey L. Tate occupies the position of Chief Financial Officer & Executive Vice President at Leggett & Platt, Inc. He is also on the board of Dow Chemical Employees' Credit Union and TCF Financial Corp. and Member of The American Institute of Certified Public Accountants, Member of Financial Executives International, Member of The Institute of Internal Auditors, Member of National Black MBA Association, Inc., Member of Omega Psi Phi Fraternity, Inc. and Member-Operating Board at The Greater Midland Community Centers, Inc. Jeffrey L. Tate previously occupied the position of Auditor for DuPont de Nemours, Inc., Finance Director at Dow Automotive and Vice President of The Dow Chemical Co. He received an undergraduate degree from The University of Alabama.

No results for this search